Clinically established biodegradable long acting injectables: An industry perspective

Adv Drug Deliv Rev. 2020 Dec:167:19-46. doi: 10.1016/j.addr.2020.11.008. Epub 2020 Nov 14.

Abstract

Long acting injectable formulations have been developed to sustain the action of drugs in the body over desired periods of time. These delivery platforms have been utilized for both systemic and local drug delivery applications. This review gives an overview of long acting injectable systems that are currently in clinical use. These products are categorized in three different groups: biodegradable polymeric systems, including microparticles and implants; micro and nanocrystal suspensions and oil-based formulations. Furthermore, the applications of these drug delivery platforms for the management of various chronic diseases are summarized. Finally, this review addresses industrial challenges regarding the development of long acting injectable formulations.

Keywords: Drug crystal suspensions; Drug crystals; Drug delivery; Extended release; Implants; In situ forming implants; Long acting injectables; Microspheres; Oil-based formulations; PLGA microparticles.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Absorbable Implants*
  • Chemistry, Pharmaceutical
  • Delayed-Action Preparations / chemistry*
  • Drug Delivery Systems / methods*
  • Drug Implants / chemistry*
  • Drug Liberation
  • Emulsions / chemistry
  • Humans
  • Microspheres
  • Nanoparticles / chemistry
  • Polylactic Acid-Polyglycolic Acid Copolymer / chemistry
  • Suspensions / chemistry

Substances

  • Delayed-Action Preparations
  • Drug Implants
  • Emulsions
  • Suspensions
  • Polylactic Acid-Polyglycolic Acid Copolymer